Your browser doesn't support javascript.
loading
Chitosan-alginate nanoparticles of cabazitaxel: Design, dual-receptor targeting and efficacy in lung cancer model.
Mehata, Abhishesh Kumar; Suseela, M Nikitha Lakshmi; Behera, Chittaranjan; Kumari, Pooja; Mahto, Sanjeev Kumar; Muthu, Madaswamy S.
Afiliación
  • Vikas; Department of Pharmaceutical Engineering and Technology, Indian Institute of Technology (BHU), Varanasi 221005, UP, India.
  • Mehata AK; Department of Pharmaceutical Engineering and Technology, Indian Institute of Technology (BHU), Varanasi 221005, UP, India.
  • Suseela MNL; Department of Pharmaceutical Engineering and Technology, Indian Institute of Technology (BHU), Varanasi 221005, UP, India.
  • Behera C; PK-PD Tox & Formulation Division, CSIR-Indian Institute of Integrative Medicine, Jammu 180001, India.
  • Kumari P; School of Biomedical Engineering, Indian Institute of Technology (BHU), Varanasi 221005, UP, India.
  • Mahto SK; School of Biomedical Engineering, Indian Institute of Technology (BHU), Varanasi 221005, UP, India.
  • Muthu MS; Department of Pharmaceutical Engineering and Technology, Indian Institute of Technology (BHU), Varanasi 221005, UP, India. Electronic address: msmuthu.phe@itbhu.ac.in.
Int J Biol Macromol ; 221: 874-890, 2022 Nov 30.
Article en En | MEDLINE | ID: mdl-36089091
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Quitosano / Nanopartículas / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Int J Biol Macromol Año: 2022 Tipo del documento: Article País de afiliación: India
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Quitosano / Nanopartículas / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Int J Biol Macromol Año: 2022 Tipo del documento: Article País de afiliación: India